Clinical trial Recruiting at 1 site Interventional Ages 13 to 18

Shame-focused cognitive behavioral therapy to reduce suicide risk in hospitalized teens

Official title: A Pilot Randomized Controlled Trial Of Shame-Focused Cognitive Behavioral Therapy For Suicide Prevention In Adolescent Psychiatric Inpatients

Run by Peking University · NCT07294001 · Data updated 2026-11-12

This program will test whether shame-focused cognitive behavioral therapy helps hospitalized teens (ages 13–18) with recent suicide attempts or severe suicidal thoughts reduce shame and lower suicide risk.

More Suicidal Ideation trials

Quick facts

Study typeInterventional
Ages13 Years to 18 Years
SexAll
Enrollment42 (estimated)
SponsorPeking University
Academic / other
Locations1 site (Beijing, Beijing Municipality)
StatusRecruiting
StartedAugust 10, 2025
Main results expectedSeptember 30, 2026
Study endsSeptember 30, 2026
Registry record updatedDecember 19, 2025
Trial IDNCT07294001 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are adolescents aged 13–18 who are hospitalized for a recent suicide attempt or severe suicidal ideation and have elevated shame (EISS ≥ 9) with a consenting parent or guardian.

Probably not a fit

Patients with current manic episodes, schizophrenia spectrum disorders, intellectual disability, expected inpatient stays under 14 days, or those unable to engage in individual therapy are unlikely to benefit from this program.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This is a single-site pilot randomized controlled trial at Peking University Sixth Hospital enrolling about 42 adolescents hospitalized for recent suicide attempt or severe suicidal ideation, randomized 2:1 to Shame-Focused CBT (SF-CBT) or supportive therapy. SF-CBT consists of seven 50–60 minute individual sessions targeting motivation, emotion recognition, shame-coping strategies, self-esteem, and relapse prevention, with three structured parent/guardian psychoeducation sessions; the comparison supportive therapy matches session dose. Primary outcomes are feasibility and acceptability (recruitment, retention, adherence, fidelity, adverse events, and user ratings), and secondary outcomes examine preliminary changes in shame, suicidal ideation, and suicidal behavior with follow-ups at 1, 3, and 6 months. The trial excludes patients with current mania, psychotic spectrum disorders, intellectual disability, very short expected stays, or other conditions that prevent participation.

Why it matters

Potential benefit: If successful, SF-CBT could provide a structured therapy that reduces shame and helps lower suicidal thoughts and behaviors in high-risk adolescents.

How similar studies have gone: Directly targeting shame is relatively novel; while CBT approaches have reduced adolescent suicidal ideation in other trials, few have tested shame-focused protocols so existing evidence is limited but promising.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Adolescents aged 13-18 years, male or female.
* Recent suicide risk, defined as:

At least one suicide attempt in the past month, or Current suicidal ideation within the past month (with or without plan/intent) and at least one previous attempt.

* Elevated shame level (baseline score ≥ 9 on the External and Internal Shame Scale, EISS).
* Adequate cognitive capacity to participate in interviews and assessments.
* Parent/legal guardian (or designated responsible adult authorized by guardian) provides informed consent and agrees to participate.

Exclusion Criteria:

* Current manic episode.
* History of schizophrenia spectrum disorder, intellectual disability, or organic brain disease.
* Severe psychiatric or medical conditions that impair capacity for consent or participation.
* Expected to receive electroconvulsive therapy (ECT) during hospitalization.
* Anticipated inpatient stay shorter than 14 days (to ensure intervention completion).

Where it's running

  • Peking University Sixth Hospital
    Beijing, Beijing Municipality, China
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.